Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 52, Issue 7 (Jul 2014)

Issues

Cardiac biomarkers and risk assessment in patients undergoing major non-cardiac surgery: time to revise the guidelines?

Aldo Clerico
  • Corresponding author
  • Department of Laboratory Medicine, Fondazione G. Monasterio CNR, Regione Toscana, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy
  • Email:
/ Michele Emdin
  • Scuola Superiore Sant’Anna and Fondazione G. Monasterio CNR, Regione Toscana, Pisa, Italy
/ Claudio Passino
  • Scuola Superiore Sant’Anna and Fondazione G. Monasterio CNR, Regione Toscana, Pisa, Italy
Published Online: 2014-02-06 | DOI: https://doi.org/10.1515/cclm-2013-0900

Abstract

Although the perioperative event rate has declined over the past 30 years, as a consequence of the developments in anesthesiology and surgical techniques, perioperative cardiovascular complications are still a significant clinical problem. At the end of the last century, a pooled analysis of several large studies found a 30-day incidence of cardiac events of 2.5% in unselected patients aged >40 years. The identification of myocardial injury after non-cardiac surgery is a problematic and tough challenge, since up to 50% of cardiac deaths actually occur in patients with no history of overt heart disease. Recently, among novel sensitive and specific cardiovascular risk markers, the European Society of Cardiology and European Society of Anesthesiology guidelines for preoperative cardiac risk assessment have recommended that preoperative brain natriuretic peptide (BNP) or N-terminal fragment of proBNP (NT-proBNP) measurement should be considered in high-risk patients undergoing non-cardiac surgery. However, several recent studies and meta-analyses, published in the last 5 years, strongly support the use of both assays of cardiac B-type natriuretic peptides and troponins, for risk stratification in patients undergoing non-cardiac surgery, in order to improve operative and postoperative outcome. Indeed, an increase in specific cardiac biomarkers, as it is the case for natriuretic peptides and troponins, always indicates that the heart is under a stress condition or even actually injured, respectively. In conclusion, the authors suggest that future guidelines on cardiovascular risk evaluation in patients undergoing major surgical procedures should take into account the following evidence.

Keywords: anesthesia; brain natriuretic peptide (BNP); cardiovascular risk; myocardial infarction; surgery; troponins

References

  • 1.

    Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, et al. An estimation of the global volume of surgery. Lancet 2008;372:139–44. [Web of Science]

  • 2.

    Poldermans D, Hoeks SE, Feringa HH. Pre-operative risk assessment and risk reduction before surgery. J Am Coll Cardiol 2008;51:1913–24. [PubMed] [Web of Science] [Crossref]

  • 3.

    Mangano DT. Adverse outcomes after surgery in the year 2001 – a continuing odyssey. Anesthesiology 1998;88:561–4. [PubMed]

  • 4.

    Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, et al. Task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery; European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30: 2769–812. [Web of Science]

  • 5.

    Struthers A, Lang C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 2007;28:1678–82. [Web of Science] [PubMed] [Crossref]

  • 6.

    Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can Med Assoc J 2005;173: 627–34.

  • 7.

    Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. J Am Med Assoc 2012;307:2295–304. [Web of Science]

  • 8.

    Grobben RB, Van Klei WA, Grobbee DE, Nathoe HM. The aetiology of myocardial injury after non-cardiac surgery. Neth Heart J 2013;21:380–8. [Crossref]

  • 9.

    Flu WJ, Schouten O, van Kuijk JP, Poldermans D. Perioperative cardiac damage in vascular surgery patients. Eur J Vasc Endovasc Surg 2010;40:1–8. [PubMed] [Crossref]

  • 10.

    Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043–9. [Crossref] [PubMed]

  • 11.

    Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 2010;152: 26–35.

  • 12.

    Biccard BM, Lurati Buse GA, Burkhart C, Cuthbertson BH, Filipovic M, Gibson SC, et al. The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2012;67:55–9. [Web of Science] [Crossref]

  • 13.

    Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 2011;124:381–7. [Crossref] [Web of Science] [PubMed]

  • 14.

    Rodseth RN. B type natriuretic peptide – a diagnostic breakthrough in peri-operative cardiac risk assessment? Anaesthesia 2009;64:165–78. [Web of Science] [PubMed] [Crossref]

  • 15.

    Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008;46:748–63. [PubMed] [Web of Science]

  • 16.

    Emdin M, Vittorini S, Passino C, Clerico A. Old and new biomarkers of heart failure. Eur J Heart Fail 2009;11:331–5. [PubMed] [Crossref]

  • 17.

    Emdin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, et al. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem 2007;53:1289–97. [Crossref]

  • 18.

    Clerico A, Giannoni A, Vittorini S, Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 2011;301:H12–20. [Web of Science]

  • 19.

    Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933–89. [Crossref]

  • 20.

    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147–239. [Crossref]

  • 21.

    Rodseth RN, Lurati Buse GA, Bolliger D, Burkhart CS, Cuthbertson BH, Gibson SC, et al. The predictive ability of pre-operative B‐type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J Am Coll Cardiol 2011;58:522–9. [Web of Science] [Crossref]

  • 22.

    Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta‐analysis of observational studies. J Am Coll Cardiol 2009;54:1599–606. [Web of Science]

  • 23.

    Cai GL, Chen J, Hu CB, Yan ML, Xu QH, Yan J. Values of plasma natriuretic peptide levels for predicting postoperative atrial fibrillation: a systematic review and meta-analysis. World J Surg 2014;38:51–9. [Crossref] [Web of Science]

  • 24.

    Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L, et al. The prognostic value of preoperative and postoperative B-type natriuretic peptides (BNP and NT proBNP) in patients having noncardiac surgery. A systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014;63:170–80. [Crossref] [PubMed]

  • 25.

    Rodseth RN, Biccard BM, Chu R, Lurati Buse GA, Thabane L, Bakhai A, et al. Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery. Systematic review and individual patient meta-analysis. Anesthesiology 2013;119:270–83. [Crossref]

  • 26.

    Weber M, Luchner A, Seeberger M, Mueller C, Liebetrau C, Schlitt A, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J 2013;34: 853–62. [PubMed] [Crossref] [Web of Science]

  • 27.

    Regenbogen SE, Lancaster RT, Lipsitz SR, Greenberg CC, Hutter MM, Gawande AA. Does the Surgical Apgar Score measure intraoperative performance? Ann Surg 2008;248:320–8. [Web of Science]

  • 28.

    Beattie WS, Karkouti K, Tait G, Steel A, Yip P, McCluskey S, et al. Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients. Can J Anesth 2012;59:1013–22. [Crossref] [Web of Science]

  • 29.

    Karakas M, Koenig W. Improved peri-operative risk stratification in non-cardiac surgery: going beyond established clinical scores. Eur Heart J 2013:34:796–8. [Crossref] [PubMed] [Web of Science]

  • 30.

    Beattie WS, Wijeysundera DN. Perioperative cardiac biomarkers: the utility and timing. Curr Opin Crit Care 2013;19:334–41. [Web of Science] [PubMed]

  • 31.

    Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal? Clin Chem Lab Med 2009;47:1167–77. [Web of Science]

  • 32.

    Clerico A, Giannoni A, Prontera T, Giovannini S. High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv Clin Chem 2009;49:1–30. [PubMed]

  • 33.

    NACB Writing Group, Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086–96.

  • 34.

    Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2009;54: e13–118. [Web of Science]

About the article

Corresponding author: Aldo Clerico, MD, Department of Laboratory Medicine, Fondazione G. Monasterio CNR, Regione Toscana, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy, Phone: +39 0585 493569, Fax: +39 0585 493652, E-mail:


Received: 2013-10-21

Accepted: 2014-01-16

Published Online: 2014-02-06

Published in Print: 2014-07-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2013-0900. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Stephen Sams, Katherine Grichnik, and Roy Soto
Anesthesiology Clinics, 2014, Volume 32, Number 3, Page 599

Comments (0)

Please log in or register to comment.
Log in